Skip to search formSkip to main contentSkip to account menu

talinolol

Known as: (+-)-N-cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea, 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (4)

Adrenergic beta-AntagonistsAnti-Arrhythmia AgentsAntihypertensive AgentsPropanolamines

Narrower (2)

cordanumtalinolol mononitrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Rapid and sensitive bioanalytical stability-indicating method for quantification of talinolol, a selective β1 adrenoceptor antagonist in lipid based formulations using ultrafast UHPLC systems.
The current study evaluates the ultra high performance liquid chromatography (UHPLC) method for the quantification of talinolol… 
2007
2007
Characterization of the Epithelial Permeation Enhancing Effect of Basic Butylated Methacrylate Copolymersin Vitro Studies
Membrane destabilizing properties and increased efflux of doxorubicin from liposomes caused by basic butylated methacrylate… 
2002
2002
St Johns wort reduces oral bioavailability of talinolol in healthy volunteers
2001
2001
An alternative hypothesis to involvement of intestinal P-glycoprotein as the cause for digoxin oral bioavailability enhancement by talinolol.
1995
1995
The actions of talinolol, a β1-selective beta blocker, in cardiac arrhythmia and acute myocardial infarction
SummaryIt has long been known that beta-receptor blocking agents, including mainly cardioselective compounds, have favourable… 
1984
1984
Influence of indometacin and acetylsalicylic acid on the therapeutic effectiveness of talinolol in patients with essential hypertension.
Clinical-pharmacological investigations on interactions between cyclo-oxygenase inhibitors and beta-adrenoceptor blocking agents… 
1984
1984
Effect of talinolol and the optical isomers of propranolol on LCAT activity in vitro.
In vitro effects of DL-propranolol (a therapeutically used beta-blocker with local anesthetic properties), L-propranolol (having… 
1981
1981
[Cardioselective beta receptor blockade in acute myocardial infarct with talinolol].
On 9 patients with acute myocardial infarction the influence of talinolol (cordanum) on haemodynamic parameters in intravenous… 
1980
1980
Compilation of Pharmacokinetic Parameters of Beta-Adrenergic Blocking Agents
After defining the drug class of β-adrenergic blocking agents, general aspects for clinical use of β-blockers are discussed… 
1979
1979
On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.